Group 6 Copy 333
0
    Please wait...

    About This Project

    An estimated 6 – 7 million people in Latin America and 300,000 U.S. citizens are infected with the protozoan parasite Trypanosoma cruzi that results in Chagas’ disease, a neglected tropical disease (NTD). Principally spread by the kissing bug (cover image), there exists an urgent need for development of new therapeutics to replace the outdated clinically used drugs, benznidazole and nifurtimox. Our research focuses on the discovery of novel antichagasic compounds for improved medicine.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Using Nanoparticles to Activate Immune Cells to Fight Tumors

    Our lab is developing a new cancer treatment which utilizes the patients own immune system to fight and kill...

    Can Data Management Tools Improve Research Efficiency and Reproducibility?

    Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

    Personalized Cancer and Viral Therapy: Clostridium-based Cell Delivery System coupled to CRISPR/Cas9 Nanotherapeutic

    One of the fundamental weaknesses in cancer treatment or any therapy based at the cellular level is entering...

    Backer Badge Funded

    A medicine project funded by 19 people